Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

425.79 -1.52 (-0.36%)
Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,338,607
Open 424.90
Bid (Size) 401.00 (5)
Ask (Size) 426.65 (1)
Prev. Close 427.31
Today's Range 423.67 - 431.67
52wk Range 283.11 - 454.95
Shares Outstanding N/A
Dividend Yield 0.80%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Overvalued Value Stocks to Sell Before June 2023
Eventually, even heavily discounted enterprises lose their charm, transitioning to become overvalued value stocks to sell. 
Via InvestorPlace
3 High-Growth Stocks to Buy Before They Join the Trillion-Dollar Club
The next trillion-dollar companies will join an elite club comprised of a handful of the most valuable firms globally. 
Via InvestorPlace

Performance

YTD
+16.66%
+16.66%
1 Month
+7.56%
+7.56%
3 Month
+34.48%
+34.48%
6 Month
+16.41%
+16.41%
1 Year
+35.84%
+35.84%

More News

Read More
Hagens Berman: Settlement Worth in Excess of $500 Million Reached in Insulin Pricing Class-Action Lawsuit
From Hagens Berman
Via Business Wire
Eli Lilly Could Launch Its Rival To Novo Nordisk's Weight-Loss Drug A Year Earlier Than Expected
Via Investor's Business Daily
$100 Invested In This Stock 20 Years Ago Would Be Worth $700 Today
Via Benzinga
Can Pfizer Stock Double Your Money in 3 Years?
Via The Motley Fool
Eli Lilly Unusual Options Activity For May 23
Via Benzinga
Eli Lilly and Company (NYSE: LLY) Climbs to New 52-Week High
Via Investor Brand Network
3 Biotech Stocks Sitting on Huge-Upside Catalysts
Via InvestorPlace
7 Top Stock Tips for June 2023
Via InvestorPlace
Zura Bio's Veteran Leadership Eyes Repeat Success, Confident Analyst Sees 150% Upside
Via Benzinga
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction
Via Benzinga
Ranked: Who Made The Most U.S. Unicorn Acquisitions Since 1997?
Via Talk Markets
Looking At Eli Lilly's Recent Unusual Options Activity
Via Benzinga
7 Stocks That Could Be the Next $2 Trillion-Dollar Companies
Via InvestorPlace
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
Via Investor's Business Daily
Microsoft To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday
Via Benzinga
Pfizer Stock Pops: Study Shows Company's Oral Weight Loss Drug Could Be As Effective As Novo Nordic's Ozempic Injection
Via Benzinga
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Via Investor's Business Daily
Lifestyle Drugs Market to Eyewitness Massive Growth : Eli Lilly, Pfizer, BMS, AstraZeneca
Via SBWire
Exposures Product Safety
The 3 Best Momentum Stocks to Buy in May 2023
Via InvestorPlace
Here's Why I Still Own Alexandria Real Estate Equities
Via The Motley Fool
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
Via Benzinga
1 Major Advantage Biogen May Have Over Pharma Giant Eli Lilly in a Multibillion-Dollar Market
Via The Motley Fool
Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Via MarketBeat
Topics Economy
Exposures Economy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.